ValoreQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMSpese di vendita, generali e amministrative595.2 M546 M579.3 M552.4 M538.6 M2.22 BRicerca e sviluppo——————Reddito operativo216.5 M326 M394.5 M396.6 M267.6 M1.38 BProventi non operativi, Totale31.2 M5.5 M-31 M1.6 M-16.1 M-40 MOneri finanziari, al netto degli interessi capitalizzati63.4 M56 M57.1 M56 M55 M224.1 MProventi non operativi, esclusi gli oneri finanziari-48.6 M-49.5 M-55.4 M-52.5 M-51.7 M-209.1 MEntrate/uscite straordinarie16.4 M-1 M-32.7 M-1.9 M-19.4 M-55 MUtile al lordo delle imposte958.8 M2.73 B2.88 B2.94 B1.1 B9.64 BQuota di utile-700 K-300 K-1.7 M-5.2 M-6.1 M-13.3 MImposte40.2 M62.2 M66.4 M75.5 M25.7 M229.8 MInteressi di minoranza200 K200 K400 K400 K200 K1.2 MAltri proventi/oneri al netto delle imposte——————Utile netto al lordo delle attività cessate143.4 M212.8 M237.9 M261.1 M164.7 M876.5 MAttività cessate0———0—Utile netto143.4 M212.8 M237.9 M261.1 M164.7 M876.5 MRegolazione della diluizione——————Dividendi privilegiati——————Utile netto diluito attribuibile agli azionisti ordinari143.4 M212.8 M237.9 M261.1 M164.7 M876.5 MUtile base per azione (EPS base)1.722.542.853.142.0110.54Utile diluito per azione (EPS diluito)1.722.522.843.121.9810.46Numero medio di azioni ordinarie in circolazione83.9 M83.6 M83.4 M83.1 M83.2 M333.3 MAzioni diluite in circolazione84.4 M84.3 M83.9 M83.7 M83.8 M335.7 MEBITDA223.8 M494.3 M568.9 M574.9 M340.8 M1.98 BEBIT53.2 M327.5 M398.6 M403.9 M167.8 M1.3 BCosto del fatturato2.43 B2.4 B2.48 B2.54 B2.52 B9.94 BAltri costi del venduto——————Ammortamento e svalutazione (liquidità)170.6 M166.8 M170.3 M171 M173 M681.1 M
Labcorp Holdings Inc
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.